Loading…

Isolating the entire pulmonary venous component versus isolating the pulmonary veins for persistent atrial fibrillation: A propensity‐matched analysis

Background The outcomes of pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) are suboptimal. The entire pulmonary venous component (PV‐Comp), consisting of the pulmonary veins, their antra, and the area between the antra, provides triggers and substrate for AF. PV‐Comp isolation...

Full description

Saved in:
Bibliographic Details
Published in:Pacing and clinical electrophysiology 2020-01, Vol.43 (1), p.68-77
Main Authors: Elbatran, Ahmed I, Gallagher, Mark M, Li, Anthony, Sohal, Manav, Bajpai, Abhay, Samir, Rania, Tawfik, Mazen, Nabil, Ahmed, Abou‐Elmaaty Nabih, Mervat, Saba, Magdi M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3572-eef6dc35fe62201a39b75df1ca71f8cfac76fe7b2077661fef30586ef2a0f2e3
cites cdi_FETCH-LOGICAL-c3572-eef6dc35fe62201a39b75df1ca71f8cfac76fe7b2077661fef30586ef2a0f2e3
container_end_page 77
container_issue 1
container_start_page 68
container_title Pacing and clinical electrophysiology
container_volume 43
creator Elbatran, Ahmed I
Gallagher, Mark M
Li, Anthony
Sohal, Manav
Bajpai, Abhay
Samir, Rania
Tawfik, Mazen
Nabil, Ahmed
Abou‐Elmaaty Nabih, Mervat
Saba, Magdi M
description Background The outcomes of pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) are suboptimal. The entire pulmonary venous component (PV‐Comp), consisting of the pulmonary veins, their antra, and the area between the antra, provides triggers and substrate for AF. PV‐Comp isolation is an alternative strategy for persistent AF ablation. Methods Among 328 patients with persistent AF who underwent a first radiofrequency ablation procedure, 200 patients (PVI, n = 100; PV‐Comp isolation, n = 100) were selected by propensity score matching. Both groups were followed up for 1 year. Results At 6‐ and 12‐month follow‐up, atrial tachyarrhythmia (AF/atrial tachycardia) recurred in 41 and 61 patients in PVI group and 22 (P = .006) and 33 patients (P 
doi_str_mv 10.1111/pace.13852
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2322741322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2338888055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3572-eef6dc35fe62201a39b75df1ca71f8cfac76fe7b2077661fef30586ef2a0f2e3</originalsourceid><addsrcrecordid>eNp9kU1OHDEQhS0UBBOSTQ4QWcoGRWrin3Hbw240IgEJiSzYtzyecjDqtjt2N2h2HIFlzpeTpDoDUcgitbCt8veeyn6EvOPshGN96q2DEy6NEntkxtWcVYarxSsyY3yuKyPN4pC8LuWWMVazuTogh5IbZnitZuTHRUmtHUL8RocboBCHkIH2Y9ulaPOW3kFMY6EudX2KeIuNXLARXsj-5kMs1KdMewRDGSaNHXKwLfVhnUM7yVI8pUva59RDLGHY_nx47OzgbmBDbbTtFoVvyL63bYG3T_sRuf58dr06ry6vvlyslpeVk0qLCsDXGzx6qIVg3MrFWquN585q7o3z1unag14LpnVdcw9eMmVq8MIyL0AekeOdLQ7zfYQyNF0oDnDKCPjwRkgh9JzjiuiHf9DbNGYcd6KkwWJKIfVxR7mcSsngmz6HDr-m4ayZ4mqmuJrfcSH8_slyXHew-YM-54MA3wH3oYXtf6yar8vV2c70F9uSpas</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2338888055</pqid></control><display><type>article</type><title>Isolating the entire pulmonary venous component versus isolating the pulmonary veins for persistent atrial fibrillation: A propensity‐matched analysis</title><source>Wiley</source><source>SPORTDiscus with Full Text</source><creator>Elbatran, Ahmed I ; Gallagher, Mark M ; Li, Anthony ; Sohal, Manav ; Bajpai, Abhay ; Samir, Rania ; Tawfik, Mazen ; Nabil, Ahmed ; Abou‐Elmaaty Nabih, Mervat ; Saba, Magdi M</creator><creatorcontrib>Elbatran, Ahmed I ; Gallagher, Mark M ; Li, Anthony ; Sohal, Manav ; Bajpai, Abhay ; Samir, Rania ; Tawfik, Mazen ; Nabil, Ahmed ; Abou‐Elmaaty Nabih, Mervat ; Saba, Magdi M</creatorcontrib><description>Background The outcomes of pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) are suboptimal. The entire pulmonary venous component (PV‐Comp), consisting of the pulmonary veins, their antra, and the area between the antra, provides triggers and substrate for AF. PV‐Comp isolation is an alternative strategy for persistent AF ablation. Methods Among 328 patients with persistent AF who underwent a first radiofrequency ablation procedure, 200 patients (PVI, n = 100; PV‐Comp isolation, n = 100) were selected by propensity score matching. Both groups were followed up for 1 year. Results At 6‐ and 12‐month follow‐up, atrial tachyarrhythmia (AF/atrial tachycardia) recurred in 41 and 61 patients in PVI group and 22 (P = .006) and 33 patients (P &lt; .001) in PV‐Comp isolation group, respectively. PV‐Comp isolation was associated with longer mean time to recurrence (PVI: 8 months, PV‐Comp isolation: 10 months, log‐rank P &lt; .001) and a lower probability of recurrence (odds ratio [OR] = 0.32; 95% confidence of interval [CI] = 0.18‐0.56, P &lt; .001), with no increase in procedural complications (PVI: 5 of 100, PV‐Comp isolation: 6 of 100, P = .76). Procedure duration was longer in PV‐Comp isolation group (PVI: 186 ± 42 min, PV‐Comp isolation: 238 ± 44 min, P &lt; .001), as well as fluoroscopy time (PVI: 22 ± 16 min, PV‐Comp isolation: 31 ± 21 min, P = .001). Conclusion PV‐Comp isolation for persistent AF reduced atrial tachyarrhythmia recurrence up to 1 year compared with PVI alone. While procedure and fluoroscopy time increased, there was no difference in procedural complications.</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/pace.13852</identifier><identifier>PMID: 31808165</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aged ; Atrial Fibrillation - surgery ; Cardiac arrhythmia ; catheter ablation ; Catheter Ablation - methods ; Egypt ; Electrocardiography ; Epicardial Mapping ; Female ; Fibrillation ; Fluoroscopy ; Humans ; London ; Male ; Middle Aged ; persistent atrial fibrillation ; posterior wall isolation ; Propensity Score ; pulmonary vein isolation ; Pulmonary Veins - surgery ; pulmonary venous component ; Recurrence ; Tachyarrhythmia ; Tachycardia ; Veins &amp; arteries</subject><ispartof>Pacing and clinical electrophysiology, 2020-01, Vol.43 (1), p.68-77</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><rights>2020 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3572-eef6dc35fe62201a39b75df1ca71f8cfac76fe7b2077661fef30586ef2a0f2e3</citedby><cites>FETCH-LOGICAL-c3572-eef6dc35fe62201a39b75df1ca71f8cfac76fe7b2077661fef30586ef2a0f2e3</cites><orcidid>0000-0003-2709-1806</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31808165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elbatran, Ahmed I</creatorcontrib><creatorcontrib>Gallagher, Mark M</creatorcontrib><creatorcontrib>Li, Anthony</creatorcontrib><creatorcontrib>Sohal, Manav</creatorcontrib><creatorcontrib>Bajpai, Abhay</creatorcontrib><creatorcontrib>Samir, Rania</creatorcontrib><creatorcontrib>Tawfik, Mazen</creatorcontrib><creatorcontrib>Nabil, Ahmed</creatorcontrib><creatorcontrib>Abou‐Elmaaty Nabih, Mervat</creatorcontrib><creatorcontrib>Saba, Magdi M</creatorcontrib><title>Isolating the entire pulmonary venous component versus isolating the pulmonary veins for persistent atrial fibrillation: A propensity‐matched analysis</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>Background The outcomes of pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) are suboptimal. The entire pulmonary venous component (PV‐Comp), consisting of the pulmonary veins, their antra, and the area between the antra, provides triggers and substrate for AF. PV‐Comp isolation is an alternative strategy for persistent AF ablation. Methods Among 328 patients with persistent AF who underwent a first radiofrequency ablation procedure, 200 patients (PVI, n = 100; PV‐Comp isolation, n = 100) were selected by propensity score matching. Both groups were followed up for 1 year. Results At 6‐ and 12‐month follow‐up, atrial tachyarrhythmia (AF/atrial tachycardia) recurred in 41 and 61 patients in PVI group and 22 (P = .006) and 33 patients (P &lt; .001) in PV‐Comp isolation group, respectively. PV‐Comp isolation was associated with longer mean time to recurrence (PVI: 8 months, PV‐Comp isolation: 10 months, log‐rank P &lt; .001) and a lower probability of recurrence (odds ratio [OR] = 0.32; 95% confidence of interval [CI] = 0.18‐0.56, P &lt; .001), with no increase in procedural complications (PVI: 5 of 100, PV‐Comp isolation: 6 of 100, P = .76). Procedure duration was longer in PV‐Comp isolation group (PVI: 186 ± 42 min, PV‐Comp isolation: 238 ± 44 min, P &lt; .001), as well as fluoroscopy time (PVI: 22 ± 16 min, PV‐Comp isolation: 31 ± 21 min, P = .001). Conclusion PV‐Comp isolation for persistent AF reduced atrial tachyarrhythmia recurrence up to 1 year compared with PVI alone. While procedure and fluoroscopy time increased, there was no difference in procedural complications.</description><subject>Aged</subject><subject>Atrial Fibrillation - surgery</subject><subject>Cardiac arrhythmia</subject><subject>catheter ablation</subject><subject>Catheter Ablation - methods</subject><subject>Egypt</subject><subject>Electrocardiography</subject><subject>Epicardial Mapping</subject><subject>Female</subject><subject>Fibrillation</subject><subject>Fluoroscopy</subject><subject>Humans</subject><subject>London</subject><subject>Male</subject><subject>Middle Aged</subject><subject>persistent atrial fibrillation</subject><subject>posterior wall isolation</subject><subject>Propensity Score</subject><subject>pulmonary vein isolation</subject><subject>Pulmonary Veins - surgery</subject><subject>pulmonary venous component</subject><subject>Recurrence</subject><subject>Tachyarrhythmia</subject><subject>Tachycardia</subject><subject>Veins &amp; arteries</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kU1OHDEQhS0UBBOSTQ4QWcoGRWrin3Hbw240IgEJiSzYtzyecjDqtjt2N2h2HIFlzpeTpDoDUcgitbCt8veeyn6EvOPshGN96q2DEy6NEntkxtWcVYarxSsyY3yuKyPN4pC8LuWWMVazuTogh5IbZnitZuTHRUmtHUL8RocboBCHkIH2Y9ulaPOW3kFMY6EudX2KeIuNXLARXsj-5kMs1KdMewRDGSaNHXKwLfVhnUM7yVI8pUva59RDLGHY_nx47OzgbmBDbbTtFoVvyL63bYG3T_sRuf58dr06ry6vvlyslpeVk0qLCsDXGzx6qIVg3MrFWquN585q7o3z1unag14LpnVdcw9eMmVq8MIyL0AekeOdLQ7zfYQyNF0oDnDKCPjwRkgh9JzjiuiHf9DbNGYcd6KkwWJKIfVxR7mcSsngmz6HDr-m4ayZ4mqmuJrfcSH8_slyXHew-YM-54MA3wH3oYXtf6yar8vV2c70F9uSpas</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Elbatran, Ahmed I</creator><creator>Gallagher, Mark M</creator><creator>Li, Anthony</creator><creator>Sohal, Manav</creator><creator>Bajpai, Abhay</creator><creator>Samir, Rania</creator><creator>Tawfik, Mazen</creator><creator>Nabil, Ahmed</creator><creator>Abou‐Elmaaty Nabih, Mervat</creator><creator>Saba, Magdi M</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2709-1806</orcidid></search><sort><creationdate>202001</creationdate><title>Isolating the entire pulmonary venous component versus isolating the pulmonary veins for persistent atrial fibrillation: A propensity‐matched analysis</title><author>Elbatran, Ahmed I ; Gallagher, Mark M ; Li, Anthony ; Sohal, Manav ; Bajpai, Abhay ; Samir, Rania ; Tawfik, Mazen ; Nabil, Ahmed ; Abou‐Elmaaty Nabih, Mervat ; Saba, Magdi M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3572-eef6dc35fe62201a39b75df1ca71f8cfac76fe7b2077661fef30586ef2a0f2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Atrial Fibrillation - surgery</topic><topic>Cardiac arrhythmia</topic><topic>catheter ablation</topic><topic>Catheter Ablation - methods</topic><topic>Egypt</topic><topic>Electrocardiography</topic><topic>Epicardial Mapping</topic><topic>Female</topic><topic>Fibrillation</topic><topic>Fluoroscopy</topic><topic>Humans</topic><topic>London</topic><topic>Male</topic><topic>Middle Aged</topic><topic>persistent atrial fibrillation</topic><topic>posterior wall isolation</topic><topic>Propensity Score</topic><topic>pulmonary vein isolation</topic><topic>Pulmonary Veins - surgery</topic><topic>pulmonary venous component</topic><topic>Recurrence</topic><topic>Tachyarrhythmia</topic><topic>Tachycardia</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elbatran, Ahmed I</creatorcontrib><creatorcontrib>Gallagher, Mark M</creatorcontrib><creatorcontrib>Li, Anthony</creatorcontrib><creatorcontrib>Sohal, Manav</creatorcontrib><creatorcontrib>Bajpai, Abhay</creatorcontrib><creatorcontrib>Samir, Rania</creatorcontrib><creatorcontrib>Tawfik, Mazen</creatorcontrib><creatorcontrib>Nabil, Ahmed</creatorcontrib><creatorcontrib>Abou‐Elmaaty Nabih, Mervat</creatorcontrib><creatorcontrib>Saba, Magdi M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elbatran, Ahmed I</au><au>Gallagher, Mark M</au><au>Li, Anthony</au><au>Sohal, Manav</au><au>Bajpai, Abhay</au><au>Samir, Rania</au><au>Tawfik, Mazen</au><au>Nabil, Ahmed</au><au>Abou‐Elmaaty Nabih, Mervat</au><au>Saba, Magdi M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isolating the entire pulmonary venous component versus isolating the pulmonary veins for persistent atrial fibrillation: A propensity‐matched analysis</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>2020-01</date><risdate>2020</risdate><volume>43</volume><issue>1</issue><spage>68</spage><epage>77</epage><pages>68-77</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>Background The outcomes of pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF) are suboptimal. The entire pulmonary venous component (PV‐Comp), consisting of the pulmonary veins, their antra, and the area between the antra, provides triggers and substrate for AF. PV‐Comp isolation is an alternative strategy for persistent AF ablation. Methods Among 328 patients with persistent AF who underwent a first radiofrequency ablation procedure, 200 patients (PVI, n = 100; PV‐Comp isolation, n = 100) were selected by propensity score matching. Both groups were followed up for 1 year. Results At 6‐ and 12‐month follow‐up, atrial tachyarrhythmia (AF/atrial tachycardia) recurred in 41 and 61 patients in PVI group and 22 (P = .006) and 33 patients (P &lt; .001) in PV‐Comp isolation group, respectively. PV‐Comp isolation was associated with longer mean time to recurrence (PVI: 8 months, PV‐Comp isolation: 10 months, log‐rank P &lt; .001) and a lower probability of recurrence (odds ratio [OR] = 0.32; 95% confidence of interval [CI] = 0.18‐0.56, P &lt; .001), with no increase in procedural complications (PVI: 5 of 100, PV‐Comp isolation: 6 of 100, P = .76). Procedure duration was longer in PV‐Comp isolation group (PVI: 186 ± 42 min, PV‐Comp isolation: 238 ± 44 min, P &lt; .001), as well as fluoroscopy time (PVI: 22 ± 16 min, PV‐Comp isolation: 31 ± 21 min, P = .001). Conclusion PV‐Comp isolation for persistent AF reduced atrial tachyarrhythmia recurrence up to 1 year compared with PVI alone. While procedure and fluoroscopy time increased, there was no difference in procedural complications.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31808165</pmid><doi>10.1111/pace.13852</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-2709-1806</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0147-8389
ispartof Pacing and clinical electrophysiology, 2020-01, Vol.43 (1), p.68-77
issn 0147-8389
1540-8159
language eng
recordid cdi_proquest_miscellaneous_2322741322
source Wiley; SPORTDiscus with Full Text
subjects Aged
Atrial Fibrillation - surgery
Cardiac arrhythmia
catheter ablation
Catheter Ablation - methods
Egypt
Electrocardiography
Epicardial Mapping
Female
Fibrillation
Fluoroscopy
Humans
London
Male
Middle Aged
persistent atrial fibrillation
posterior wall isolation
Propensity Score
pulmonary vein isolation
Pulmonary Veins - surgery
pulmonary venous component
Recurrence
Tachyarrhythmia
Tachycardia
Veins & arteries
title Isolating the entire pulmonary venous component versus isolating the pulmonary veins for persistent atrial fibrillation: A propensity‐matched analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T14%3A40%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isolating%20the%20entire%20pulmonary%20venous%20component%20versus%20isolating%20the%20pulmonary%20veins%20for%20persistent%20atrial%20fibrillation:%20A%20propensity%E2%80%90matched%20analysis&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=Elbatran,%20Ahmed%20I&rft.date=2020-01&rft.volume=43&rft.issue=1&rft.spage=68&rft.epage=77&rft.pages=68-77&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/pace.13852&rft_dat=%3Cproquest_cross%3E2338888055%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3572-eef6dc35fe62201a39b75df1ca71f8cfac76fe7b2077661fef30586ef2a0f2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2338888055&rft_id=info:pmid/31808165&rfr_iscdi=true